Back to mobile site

More on ELVN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+22.8% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/19/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Enliven Therapeutics, Inc (NQ:ELVN)
Delayed: 45.10 +0.24 (0.53%)
Prev. Close $44.86  
Open$45.01 
52 Wk High$ 
52 Wk Low$ 
Day High$45.72 
Day Low$44.22 
P/E N/A  
EPS$ 
Volume2,449,817 

Friends, Peers and Foes (?): ALLO, CHRS, ONCY PYXS (more...)

Jun 17, 2026 07:45 PM Form 4 Enliven Therapeutics, For: Jun 15 Filed by: OrbiMed Genesis GP LLC
Jun 17, 2026 07:42 PM Form SCHEDULE 13D/A Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC
Jun 17, 2026 04:25 PM Form 144 Enliven Therapeutics, Filed by: Hohl Benjamin
Jun 15, 2026 09:24 PM Form 144 Enliven Therapeutics, Filed by: ORBIMED CAPITAL LLC
Jun 15, 2026 09:21 PM Form 144 Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC
Jun 15, 2026 09:19 PM Form 144 Enliven Therapeutics, Filed by: ORBIMED ADVISORS LLC
Jun 15, 2026 04:40 PM ENLIVEN Therapeutics closes $460M public stock offering
Jun 15, 2026 04:40 PM Enliven Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Jun 12, 2026 04:56 PM Form 8-K Enliven Therapeutics, For: Jun 11
Jun 12, 2026 04:53 PM Form 424B5 Enliven Therapeutics,
View All Articles

Entities mentioned with ELVN

View All Entities